Dr. Winn is a physician-scientist board certified in Maternal-Fetal Medicine with a PhD in Biochemistry. She is a leading expert in human placental development and preeclampsia pathogenesis. She leads an active NIH funded basic and translational research program. Dr. Winn’s research program focuses on both normal and abnormal human placental development and related obstetrical complications, particularly preeclampsia. Her laboratory also investigates the impact of pregnancy, and specifically placental factors, on the maternal immune and endothelial systems. Dr. Winn’s mission is to improve maternal and child health while training the next generation of perinatal researchers.
Preeclampsia: Challenges of Personalized Medicine When There Are Two
The health of a pregnancy is determined by the maternal, placental and fetal units. Therefore, consideration of personalized medicine in pregnancy requires examination of the interplay of two genomes and the subsequent impact on biology. Preeclampsia, a leading cause of maternal and neonatal morbidity and mortality, will demonstrate the challenges in the field.